Author

Mikko Myllymäki

Broad InstituteORCID 0000-0002-8194-7356Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1

Frequent Co-Authors

Aarno V. PalotieiD· 1 shared Aleksandr IanevskiiD· 1 shared Andrea GannaiD· 1 shared Anna Näätänen· 1 shared Aoxing LiuiD· 1 shared Christopher James GibsoniD· 1 shared Christopher R. ReillyiD· 1 shared Constantine S. MitsiadesiD· 1 shared

Activity by Year

2021-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Aarno V. PalotieORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 17, 2026

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface

Jonas Bouhlal, Emmi Jokinen, Petra Johanna Nygren…·Satu M. Mustjoki

The paper identifies drugs that rewiring the cancer-immune interface by enhancing NK cell function and tumor susceptibility through multimodal screening approaches.

DOI 10.64898/2026.04.13.717771

humanbulk RNA-seq

𝕏 PostBluesky

GeneticsBloodPeer-reviewedMay 21, 2021

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Christopher R. Reilly, Mikko Myllymäki, Robert Allyn Redd…·Robert Coleman Lindsley

The paper identifies TERT rare variants in MDS patients, showing shorter telomeres, younger age at diagnosis, and worse survival, suggesting their role in MDS pathogenesis and transplant outcomes.

51 citationstop 3%

humanstatistical model

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintMay 7, 2021

Genetic variant in SPDL1 reveals novel mechanism linking pulmonary fibrosis risk and cancer protection

Jukka T. Koskela, Paavo Häppölä, Aoxing Liu…·Mark J. Daly

The paper identifies a genetic variant in SPDL1 that links pulmonary fibrosis risk and cancer protection through antagonistic pleiotropy.

8 citations

humanGWAS summary statistics

𝕏 PostBluesky